The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
Supports production of AbbVie's current and next-generation immunology and neuroscience medicines
The agreement responds directly to President Trump’s demands that drugmakers cut costs for US patients
The work will leverage ProBioGen’s CHO.RiGHT expression platform, powered by its proprietary DirectedLuck transposase technology, alongside PsiBot smart automation
Pravesh brings with him over 29 years of experience in leading complex manufacturing operations and driving operational excellence
Transcenta will grant EirGenix a non-exclusive license to its Highly Intensified Continuous Bioprocessing (HiCB) platform
The plant is expected to enhance regional supply capabilities
Subscribe To Our Newsletter & Stay Updated
